Related references
Note: Only part of the references are listed.UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Eric F. Pettersen et al.
PROTEIN SCIENCE (2021)
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Pengfei Yang et al.
AGEING RESEARCH REVIEWS (2020)
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel et al.
FRONTIERS IN PHARMACOLOGY (2020)
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane
Jie Yin et al.
NATURE (2020)
Conformational transitions of a neurotensin receptor 1-Gi1 complex
Hideaki E. Kato et al.
NATURE (2019)
Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870
Ye Zhou et al.
ELIFE (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
GPCRdb in 2018: adding GPCR structure models and ligands
Gaspar Pandy-Szekeres et al.
NUCLEIC ACIDS RESEARCH (2018)
Guidelines for using Bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs
J. Bernard Heymann
PROTEIN SCIENCE (2018)
ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps
Tristan Ian Croll
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2018)
Cryo-EM structure of human rhodopsin bound to an inhibitory G protein
Yanyong Kang et al.
NATURE (2018)
Structure of the adenosine-bound human adenosine A(1) receptor-G(i) complex
Christopher J. Draper-Joyce et al.
NATURE (2018)
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Sheng Wang et al.
NATURE (2018)
Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go
Javier Garcia-Nafria et al.
NATURE (2018)
Development of an antibody fragment that stabilizes GPCR/G-protein complexes
Shoji Maeda et al.
NATURE COMMUNICATIONS (2018)
Dominant Negative G Proteins Enhance Formation and Purification of Agonist-GPCR-G Protein Complexes for Structure Determination
Yi-Lynn Liang et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2018)
POVME 3.0: Software for Mapping Binding Pocket Flexibility
Jeffrey R. Wagner et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2017)
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Shawn Q. Zheng et al.
NATURE METHODS (2017)
D4 dopamine receptor high-resolution structures enable the discovery of selective agonists
Sheng Wang et al.
SCIENCE (2017)
Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons
Tobias Weinert et al.
NATURE COMMUNICATIONS (2017)
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Andrew S. Dixon et al.
ACS CHEMICAL BIOLOGY (2016)
The structural basis of the dominant negative phenotype of the Gαi1β1γ2 G203A/A326S heterotrimer
Ping Liu et al.
ACTA PHARMACOLOGICA SINICA (2016)
Gctf: Real-time CTF determination and correction
Kai Zhang
JOURNAL OF STRUCTURAL BIOLOGY (2016)
The dopamine theory of addiction: 40 years of highs and lows
David J. Nutt et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Generic GPCR residue numbers - aligning topology maps while minding the gaps
Vignir Isberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Dopamine Receptors and Neurodegeneration
Claudia Rangel-Barajas et al.
AGING AND DISEASE (2015)
Dopamine receptors - IUPHAR Review 13
Jean-Martin Beaulieu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Alpha-Bulges in G Protein-Coupled Receptors
Rob van der Kant et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Molecular control of δ-opioid receptor signalling
Gustavo Fenalti et al.
NATURE (2014)
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Sjors H. W. Scheres
JOURNAL OF STRUCTURAL BIOLOGY (2012)
Dopamine D1, D2, D3 Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain
Jianjun Sun et al.
PLOS ONE (2012)
Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Eugene Chun et al.
STRUCTURE (2012)
RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite
Sarel J. Fleishman et al.
PLOS ONE (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Ellen Y. T. Chien et al.
SCIENCE (2010)
G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors
J. Robert Lane et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Dopamine D3 receptor agonists for protection and repair in Parkinson's disease
Jeffrey N. Joyce et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists
Trond Kvernmo et al.
CLINICAL THERAPEUTICS (2006)
Automated electron microscope tomography using robust prediction of specimen movements
DN Mastronarde
JOURNAL OF STRUCTURAL BIOLOGY (2005)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Central mechanisms regulating penile erection in conscious rats: The dopaminergic systems related to the proerectile effect of apomorphine
GC Hsieh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
R Holloway et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011):: A potent and selective dopamine D3 receptor antagonist with high oral bioavailability and CNS penetration in the rat
G Stemp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
